CARBOPLATIN - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE TREATMENT OF CANCER

被引:172
作者
WAGSTAFF, AJ
WARD, A
BENFIELD, P
HEEL, RC
机构
关键词
D O I
10.2165/00003495-198937020-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:162 / 190
页数:29
相关论文
共 132 条
[41]  
GAYNON P, 1988, ASCO, V7, pA312
[42]  
GEORGE M, 1988, ASCO, V7, pA539
[43]  
GERMA JR, 1987, ECCO 4, P63
[44]  
GIL A, 1987, ECCO MADRID 1101, P42
[45]  
GORE ME, 1986, BRIT J CANCER, V54, P200
[46]   PRIMING REDUCES THE BONE-MARROW TOXICITY OF CARBOPLATIN [J].
GORE, ME ;
HILLS, CA ;
SIDDIK, ZH ;
SLOANE, JP ;
WINKLEY, AR ;
SMITH, IE ;
MILLAR, JL .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (01) :75-80
[47]   CARBOPLATIN (CBDCA), IPROPLATIN (CHIP), AND HIGH-DOSE CISPLATIN IN HYPERTONIC SALINE EVALUATED FOR TUBULAR NEPHROTOXICITY [J].
GOREN, MP ;
FORASTIERE, AA ;
WRIGHT, RK ;
HOROWITZ, ME ;
DODGE, RK ;
KAMEN, BA ;
VIAR, MJ ;
PRATT, CB .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 19 (01) :57-60
[48]  
GORMLEY PE, 1979, CLIN PHARMACOL THER, V25, P351
[49]  
GOSS G, 1988, ASCO, V7, pA837
[50]  
HARLAND SJ, 1984, CANCER RES, V44, P1693